News tagged with naltrexone
Opioid-blocking medication reduces brain's response to alcoholism cues
Researchers at Harvard-affiliated McLean Hospital have produced the first evidence that the opioid blocker extended-release injectable naltrexone (XR-NTX) is able to reduce the brain's response to cues that may cause alcoholics ...
Medicine & Health / Medical research
May 26, 2010 |
5 / 5 (2) |
0
Pathological gambling may be successfully treated with medications for substance addiction
Pathological gambling can be successfully treated with medications that decrease urges and increase inhibitions, according to researchers at the annual meeting of the American College of Neuropsychopharmacology (ACNP). Researchers ...
Medicine & Health / Psychology & Psychiatry
Dec 10, 2009 |
5 / 5 (1) |
0
Oral naltrexone can reduce health care costs
Alcohol-use disorders (AUDs), referring to both alcohol abuse and alcohol dependence, affect nearly 8.5 percent of the American population, are associated with numerous medical, psychiatric, family, legal, and work-related ...
Apr 05, 2010 |
4 / 5 (1) |
1
Acamprosate prevents relapse to drinking in alcoholism
Acamprosate reduces the number of patients being treated for alcoholism who return to drinking, according to a new Cochrane Systematic Review. The drug showed moderate benefits in trials when used in addition to non-drug treatm ...
Medicine & Health / Medications
Sep 08, 2010 |
4 / 5 (1) |
1
Alcoholics can curb drinking with use of a pill
A little-used medication can help treat alcoholism, an updated review of studies confirms.
Dec 15, 2010 |
4 / 5 (1) |
0
Naltrexone
Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. It is marketed in generic form as its hydrochloride salt, naltrexone hydrochloride, and marketed under the trade names Revia and Depade. In some countries including the United States, a once-monthly extended-release injectable formulation is marketed under the trade name Vivitrol. Also in the US, Methylnaltrexone Bromide, a closely related drug, is marketed as Relistor, for the treatment of opioid induced constipation.
Naltrexone should not be confused with naloxone (which is used in emergency cases of overdose rather than for longer-term dependence control) nor nalorphine. Both nalorphine and naloxone are full antagonists and will treat an opioid overdose, but naltrexone is longer-acting than naloxone (although neither is an irreversible antagonist like naloxazone), making naloxone a better emergency antidote.
For more information about Naltrexone, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
